ADHD adolescents children CME Continuum diagnosis education eLearning online treatment

national faculty

Germany

KohnsDr Ulrich Kohns

Paediatrician and Child Psychotherapist, Essen, Germany

Dr Ulrich Kohns received his medical qualifications at the universities of Marburg and Essen, and has been a practising paediatrician since 1980 and a child psychotherapist since 1990. In 2008, he was awarded the Federal Cross of Merit for his work in child protection and in improving the care of children and adolescents with ADHD.

Disclosures: Dr Kohns has received honoraria from Lilly, Shire and Medice. He has not undertaken any research on ADHD medications funded by these companies.

scroll to top

RoessnerProfessor Dr Veit Rößner

Chair and Medical Director, Child and Adolescent Psychiatry and Psychotherapy Department, Carl Gustav Carus University Hospital, Dresden University of Technology, Germany

Professor Dr Veit Roessner obtained his medical degree in 2000 at the Friedrich-Alexander-University in Erlangen. He joined the University of Gӧttingen as a consultant at the specialist outpatient clinic for patients with ADHD, tic disorders and obsessive compulsive disorders (OCD) in 2005, and became assistant medical director of the Department of Child and Adolescent Psychiatry and Psychotherapy in 2006.

Professor Dr Roessner’s substantial research and clinical experience spans ADHD, OCD, autism spectrum disorders, tic disorders and Tourette’s syndrome, for which he won the German Tourette Society’s Scientific Award in 2007. Professor Dr Roessner is on the executive boards of the German Society of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, and the European Society for Study of Tourette’s Syndrome. He is also on the editorial board of several peer-review journals.

Disclosures: Professor Dr Roessner has been a consultant and has written materials for Lilly, Novartis and Shire. He has received honoraria as a speaker from Lilly, Novartis, Shire and Medice, and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials funded by Novartis, Shire and Otsuka companies.

scroll to top

SobanskiDr Esther Sobanski

Associate Professor of Child and Adolescent Psychiatry, Central Institute of Mental Health, Mannheim, Germany

Dr Esther Sobanski holds a board certification both in general and child / adolescent psychiatry and psychotherapy. She heads the clinical research group on adult ADHD at the Central Institute of Mental Health in Mannheim, where she has published extensively in the field. Her research has encompassed the clinical and psychosocial features of ADHD, as well as pharmacological and psychotherapeutic interventions and neuropsychological issues. She is a member of the European Adult ADHD Network, aiming to increase awareness of this disorder and improve knowledge and patient care by providing education and establishing research links.

Disclosures: Dr Sobanski has been on advisory boards for Shire, Eli Lilly and Medice. She has also delivered lectures for Eli Lilly and Medice and has conducted phase-III-studies and investigator initiated trials within the last 5 years for Eli Lilly, Medice and Novartis.

scroll to top

SkrodzkiDr Klaus Skrodzki

Paediatrician and Paediatric Cardiologist, Paediatrician Praxis, Forchheim, Germany

Dr Klaus Skrodzki lectured in rehabilitation for handicapped children at the Humboldt University of Berlin, and has been a practising paediatrician since 1982. He has more than 30 years of clinical experience in ADHD and is the deputy chair of the Association of Peadiatrician ADHD Specialists in Germany and in the Leadership of the Support Group ADHD-Germany. Dr Skrodzki has edited or co-authored several books on ADHD and is on the Scientific ADHD Advisory Board of the German Medical Association.

Disclosures: Lectures for colleagues, and member of advisory boards sponsored by Eli Lilly, Medice, Novartis and Shire.

scroll to top

StollhoffDr Kirsten Stollhoff

Specialist in Neuropaediatric Medicine, Hamburg-Altona, Germany

Dr Kirsten Stollhoff is a practising specialist in neuropaediatric medicine at a private community practice focusing on paediatric neurology. Her strong experience in treating patients with ADHD has led her to becoming chair of the Association of Child and Adolescent ADHD Specialists (AG ADHS der Kinder- und Jugendärzte) and secretary of the Association of Office-based Neuropaediatricians (AGNNP). In addition, she is a member of the editorial board for Paediatrics at First Hand (Päediatrie Hautnah) and has published articles in a number of medical journals.

Disclosures: Dr Stollhoff has served in an advisory or consultancy role for Ärztekammer Hamburg, Berufsverband der Kinder- und Jugendarzte e.V. (BVKJ), Jansen, Medice, Novartis and Shire.

scroll to top

Male national faculty memberProfessor Michael Rösler

Biography coming soon.
 
 
 
 
scroll to top

Spain

miguel-casasProfessor Miguel Casas

Professor of Psychiatry, Department of Psychiatry and Legal Medicine, School of Medicine, Autonomous University of Barcelona, Spain

Director, Department of Psychiatry, Vall d’Hebron University Hospital, Barcelona, Spain

Professor Miguel Casas leads the Psychiatry, Mental Health and Addictions Research Group at the Vall d’Hebron University Hospital, where he was appointed director of the psychiatry department in 2000. With research interests spanning ADHD, addictions and borderline personality disorders, Professor Casas has recently linked up with the Mental Health Research Centre (CIBERSAM) at the Carlos III Institute of Health. Since 1998, he has also been the scientific director for the Treatment Programme for Doctors with Psychiatric and Addictive Disorders (PAIME). He is a member of a number of professional, scientific and non-profit organisations and is on the editorial board of several journals in psychiatry and addictions.

Disclosures: Professor Casas has received funding from Lilly, Shire, Janssen Pharmaceutical, Pfizer, OTSUKA, Reckitt, ADAMET and Ferrer Group.

scroll to top

Garcia-CruzDr José Miguel García Cruz

Paediatrician, EAP San Martin, Osakidetza, Vitoria-Gasteiz, Alava, Spain

Dr José Miguel García Cruz obtained his medical degree at the University of Zaragoza, and has been a paediatrician at the University of the Basque Country since 1982. He is vice-president of the Vasco Navarra Society of Paediatricians (SVNP) and a member of the ADHD group at the Spanish Paediatrics Society (AEPap). He is active in ADHD research, with publications and abstracts in European and International Congresses.

Disclosures: none.

scroll to top
 

Fernandez-PerezDr Maximino Fernández Pérez

Tenured Paediatrician, La Felguera Health Centre, Asturias, Spain

Manager, Integral and Multidisciplinary Centre for Paediatrics and Pyschology (CIMAX), Gijón, Spain

Dr Fernández Pérez obtained his medical degree from the University of Valladolid in 1982 and specialised in paediatrics at the Covadonga mother and child hospital in Oviedo, receiving his doctorate in 1991. He has served on the editorial boards of the Academic Pediatrics’ journal, Pediatrics in Review – Spanish Edition, for 20 years. He was the coordinator for ADHD in Primary Care Society for 4 years, and is currently on the board of directors of Spanish Association of Pediatrics’ (AEP) Child Psychiatry Society. He obtained his degree in Clinical and Educational Psychology from UNED. He holds a fellowship in child and adolescent psychiatry from the University of Navarra, and is a member of the steering committee at Project PANDAH, which is investigating the unmet needs among ADHD professionals in Spain.

Disclosures: Dr Fernández Pérez has received funding from the Health and Education Departments of the Asturias Province, and from the University of Oviedo. He has also received funding from Janssen, Rubió, Juste and Glaxo. He is currently a consultant for and has received honoraria from Shire.

scroll to top

PenzolDr Maria Jose Penzol

Psychiatrist Research Collaborator, Child and Adolescent Psychiatry Department, The Health Research Institute of the Hospital Gregorio Marañón (IISGM), Hospital General Universitario Gregorio Marañón (HGUGM), CIBERSAM, Madrid, Spain

Former Head of Child and Adolescent Psychiatry Department, Hospital Infante D Pedro, Aveiro, Portugal (2006–2009)

Dr María José Penzol is a child and adolescent psychiatrist with over 15 years of clinical experience in youth mental health and systemic family therapy in Portugal and Spain. She has an MSc in child and adolescent mental health from the Institute of Psychiatry at the Maudsley Hospital (King’s College London, UK). Since 2012, she has been involved in several research projects focused on child and adolescent psychiatry. She is currently participating in European multicentre projects, studying the effectiveness of therapeutic interventions for child and adolescent conduct disorder.

Disclosures: none.

scroll to top

Ruiz-VeguillaDr Miguel Ruiz-Veguilla

Consultant Psychiatrist, Neurodevelopment and Psychosis, the Institute of Biomedicine of Seville (IBIS), Virgen del Rocio University Hospital / the Spanish Scientific Research Council (CSIC) / The University of Seville, UGC Salud Mental HVR, Sevilla, Spain

Dr Miguel Ruiz-Veguilla leads the neurodevelopmental and psychosis group at the Virgen del Rocio University Hospital and the Institute of Biomedicine of Seville (IBiS). He is also a practising clinician involved in the assessment and treatment of neuropsychiatric disorders among adolescents and adults. To date, he has authored 16 peer-reviewed articles, including three on ADHD.

Disclosures: Dr Ruiz-Veguilla has received honoraria or grants from Bristol-Myers Squibb, Instituto de Salud Carlos III, Janssen Cilag, Lundbeck, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Consejeria de Salud de la Junta de Andalucia, Otsuka and Plan Nacional de Drogas.

scroll to top

Male national faculty memberDr Javier Royo Moya

Biography coming soon.
 
 
 
 
scroll to top

Sweden

FernellProfessor Elisabeth Fernell

Professor of Child and Adolescent Psychiatry, Gillberg Neuropsychiatry Centre, Gothenburg University, Sweden

Neuropaediatrician, Unit of Developmental Disorders, Department of Paediatrics, Skaraborg Hospital, Mariestad, Sweden

Professor Elisabeth Fernell’s clinical and research interests include developmental disorders, particularly intellectual disability, autism spectrum disorders and ADHD, and she has published over 100 peer-reviewed papers in these areas. Before being appointed professor of child and adolescent psychiatry at the Gillberg Centre, she was associate professor of paediatrics at the Karolinska Institute in Stockholm for many years. Her clinical practice now focuses on children and adolescents with ADHD and co-occurring conditions.

Disclosures: none.

scroll to top

GustafssonDr Peik Gustafsson

Senior Physician, Department of Child and Adolescent Psychiatry, University Hospital of Malmö, Malmö, Sweden

Dr Peik Gustafsson obtained his medical qualifications at Lund University in 1988, specialising in child and adolescent psychiatry in 1994. He is the director of studies in the Department of Child and Adolescent Psychiatry at the University Hospital of Malmö, where he is also a practising senior physician and supervises a number of doctoral candidates.
His particular research interest is neurodevelopmental disorders, for which he was awarded a PhD in 2008 for his work on the biosocial aspects of ADHD, while his clinical work also encompasses autism spectrum disorders and Tourette’s syndrome.

Disclosures: Dr Gustafsson has received honoraria for speaking engagements with Lilly, Novartis and Janssen. He has also been on an advisory board for Lilly related to ADHD pharmacotherapy and has participated in expert meetings funded by Shire.

scroll to top

LindstromDr Katarina Lindström

Neuropaediatrician, Astrid Lindgren Children´s Hospital, Karolinska University Hospital, Huddinge, Sweden

Katarina Lindström is a neuropaediatrician and has been working clinically at Astrid Lindgren Children´s Hospital, Karolinska University Hospital, Huddinge for more than 20 years. Her role comprises assessing and treating children and adolescents with suspected neurodevelopmental disorders, mainly autism spectrum disorders and ADHD, and participating in pharmacological clinical trials. Katarina is also involved in clinical research in the field of long-term follow up of children with different perinatal events, such as asphyxia, post-maturity and congenital infections.

Disclosures: Katarina has received support for conferences from Shire and Lilly. She has received honoraria as a speaker from Lilly.

scroll to top

WestinDr Marcus Westin

Senior Consultant, Akademiska Sjukhuset, Uppsala University Hospital, Sweden

Dr Marcus Westin obtained his medical degree at the University of Uppsala in 1996, and is now a senior consultant at the Akademiska Sjukhuset, Uppsala University Hospital, in Sweden. He was board certified in child and adolescent psychiatry in 2007 and completed his PhD in the same year, studying healthcare usage among single-parent families. He also holds board certification in social medicine.

Disclosures: Dr Westin has received funding from Lilly, Shire and Janssen to attend national and international conferences.

scroll to top